Incyte Corp, a pharmaceutical research company focused on developing cancer therapies, announced this morning that it’s partnering with the Abramson Cancer Center at the University of Pennsylvania, a hub for cancer research.
The goal of the collaboration is to share the knowledge and expertise of top drug discovery and development scientists.
In the long-term, the aim is to better understand cancer biology and foster innovation in the practice of immunotherapy, and improve patient outcomes more quickly.
- Advertisement -
Incyte’s research and development team will work jointly with scientists from Abramson to come up with a collaborative model.
